172 related articles for article (PubMed ID: 35717615)
1. Connexin 43, Bcl-2, Bax, Ki67, and E-cadherin patterns in oral squamous cell carcinoma and its relationship with GJA1 rs12197797 C/G.
Segura IG; Secchi DG; Galíndez MF; Carrica A; Bologna-Molina R; Brunotto M; Centeno VA
Med Oral Patol Oral Cir Bucal; 2022 Jul; 27(4):e366-e374. PubMed ID: 35717615
[TBL] [Abstract][Full Text] [Related]
2. Bax expression measured by AQUAnalysis is an independent prognostic marker in oral squamous cell carcinoma.
Bose P; Klimowicz AC; Kornaga E; Petrillo SK; Matthews TW; Chandarana S; Magliocco AM; Brockton NT; Dort JC
BMC Cancer; 2012 Aug; 12():332. PubMed ID: 22852863
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of COX-2, Ki-67, Bcl-2, Bax, VEGF and CD105 according to histological grading in oral squamous cell carcinoma.
Escobar E; Gómez-Valenzuela F; Peñafiel C; Hormazábal-Hevia A; Herrera-Fuentes C; Mori-Aliaga D
Rev Esp Patol; 2023; 56(3):147-157. PubMed ID: 37419553
[TBL] [Abstract][Full Text] [Related]
4. Epithelial-mesenchymal transition (EMT) markers have prognostic impact in multiple primary oral squamous cell carcinoma.
da Silva SD; Morand GB; Alobaid FA; Hier MP; Mlynarek AM; Alaoui-Jamali MA; Kowalski LP
Clin Exp Metastasis; 2015 Jan; 32(1):55-63. PubMed ID: 25433796
[TBL] [Abstract][Full Text] [Related]
5. Changed expression of E-cadherin and galectin-9 in oral squamous cell carcinomas but lack of potential as prognostic markers.
Chan SW; Kallarakkal TG; Abraham MT
Asian Pac J Cancer Prev; 2014; 15(5):2145-52. PubMed ID: 24716948
[TBL] [Abstract][Full Text] [Related]
6. Immunoexpression of Epithelial Mesenchymal Transition Proteins E-Cadherin, β-Catenin, and N-Cadherin in Oral Squamous Cell Carcinoma.
Angadi PV; Patil PV; Angadi V; Mane D; Shekar S; Hallikerimath S; Kale AD; Kardesai SG
Int J Surg Pathol; 2016 Dec; 24(8):696-703. PubMed ID: 27312520
[TBL] [Abstract][Full Text] [Related]
7. The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage.
Pannone G; Santoro A; Feola A; Bufo P; Papagerakis P; Lo Muzio L; Staibano S; Ionna F; Longo F; Franco R; Aquino G; Contaldo M; De Maria S; Serpico R; De Rosa A; Rubini C; Papagerakis S; Giovane A; Tombolini V; Giordano A; Caraglia M; Di Domenico M
Curr Cancer Drug Targets; 2014; 14(2):115-27. PubMed ID: 24274398
[TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of immunohistochemical expression of MCM2 and Ki67 in oral epithelial dysplasia and oral squamous cell carcinoma.
Swain S; Nishat R; Ramachandran S; Raghuvanshi M; Behura SS; Kumar H
J Cancer Res Ther; 2022; 18(4):997-1002. PubMed ID: 36149152
[TBL] [Abstract][Full Text] [Related]
9. Oral squamous cell carcinoma is associated with decreased bcl-2/bax expression ratio and increased apoptosis.
Loro LL; Vintermyr OK; Liavaag PG; Jonsson R; Johannessen AC
Hum Pathol; 1999 Sep; 30(9):1097-105. PubMed ID: 10492046
[TBL] [Abstract][Full Text] [Related]
10. Subcellular localization and expression of E-cadherin and SNAIL are relevant since early stages of oral carcinogenesis.
Lopes NM; Xavier FCA; Ortiz RC; Amôr NG; Garlet GP; Lara VS; Batista AC; Costa NL; Rodini CO
Pathol Res Pract; 2018 Aug; 214(8):1185-1191. PubMed ID: 29970306
[TBL] [Abstract][Full Text] [Related]
11. Expression of Bcl-2 family proteins and association with clinicopathological characteristics of oral squamous cell carcinoma.
Coutinho-Camillo CM; Lourenço SV; Nishimoto IN; Kowalski LP; Soares FA
Histopathology; 2010 Aug; 57(2):304-16. PubMed ID: 20716171
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Potential of N-Cadherin in Oral Squamous Cell Carcinoma via Immunohistochemical Methods.
Chandolia B; Rajliwal JP; Bajpai M; Arora M
J Coll Physicians Surg Pak; 2017 Aug; 27(8):475-478. PubMed ID: 28903838
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of CK19 and VEGF gene expression, ki67 antigen, p53 protein, C-erb-B2, and their relationship in oral squamous cell carcinoma.
Shen Y; Xu Z; Liu M; Piao S; Li J
Cell Mol Biol (Noisy-le-grand); 2022 Feb; 67(5):233-239. PubMed ID: 35818248
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis and expression of Bax and Bcl-2 in snuff- and non-snuff associated oral squamous cell carcinomas.
Loro LL; Vintermyr OK; Ibrahim SO; Idris AM; Johannessen AC
Anticancer Res; 2000; 20(5A):2855-60. PubMed ID: 11062693
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression of Bcl-2 in oral epithelial dysplasia and oral squamous cell carcinoma.
Juneja S; Chaitanya NB; Agarwal M
Indian J Cancer; 2015; 52(4):505-10. PubMed ID: 26960459
[TBL] [Abstract][Full Text] [Related]
16. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of Bcl-2 and Bax protein expression in the patients with oral squamous cell carcinoma.
Zhang M; Zhang P; Zhang C; Sun J; Wang L; Li J; Tian Z; Chen W
J Oral Pathol Med; 2009 Mar; 38(3):307-13. PubMed ID: 18710422
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of oral squamous cell carcinoma: a tissue microarray study.
Solomon MC; Carnelio S; Gudattu V
Indian J Cancer; 2010; 47(2):166-72. PubMed ID: 20448381
[TBL] [Abstract][Full Text] [Related]
19. [Expression and clinical significance of NEK2 and EMT related molecules in oral squamous cell carcinoma].
Ye TT; Chen WH; Pei J; Jia YX; Wu HY
Shanghai Kou Qiang Yi Xue; 2023 Dec; 32(6):640-644. PubMed ID: 38494974
[TBL] [Abstract][Full Text] [Related]
20. Association between COVID 19 exposure and expression of malignant pathological features in oral squamous cell carcinoma: A retrospective cohort study.
Hua Y; Ma P; Li C; Gao N; Ding Z
Oral Oncol; 2024 Apr; 151():106740. PubMed ID: 38489898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
